SheMed provides personalized weight-loss programs tailored for women, combining clinical care, diagnostics, and digital health tools into a single subscription experience. The platform integrates medical oversight with lifestyle guidance to deliver structured and safe treatment plans.
Its offering includes educational content on diet, exercise, and women’s health, alongside a monthly physical subscription box and a mobile app that tracks progress and enables regular check-ins. SheMed operates within the disease self-management and preventive healthcare space.
What Is SheMed and What Does It Do?
SheMed, founded in 2024, is a London-based digital health company delivering clinically supervised weight-loss programs for women. The company combines at-home blood testing, medical reviews, and digital tracking to offer personalized care pathways.
SheMed’s programs include monthly clinician reviews, symptom management, educational resources, and a subscription box containing treatment essentials and women’s health materials. Its all-in-one app enables progress tracking, weekly check-ins, and access to clinician-written guidance.
How Much Funding Has SheMed Raised?
1. Series A
- Amount Raised: $50M
- Date: October 2025
- Motivation: To scale women-focused weight-loss programs, expand clinical infrastructure, and enhance digital health capabilities.
Total Funding Raised: $50 Million
Current Valuation: $1 Billion (as of Oct 2025)
Latest Funding Date: October, 2025
Key Investors
1. Investors
- Details: Institutional investors backing SheMed’s Series A round.
- Investment Focus Areas: Digital health, disease self-management, women’s healthcare.
- Notable Investments: SheMed.
Where Is SheMed’s Headquarters?
SheMed is headquartered in London, United Kingdom, providing access to the UK’s healthcare ecosystem, clinical talent, and health-tech innovation landscape.
What’s Next for SheMed?
SheMed is positioned to expand its clinical programs, improve diagnostic personalization, and grow its subscriber base across the UK and potentially international markets. With strong Series A backing, the company is expected to invest in technology, regulatory expansion, and long-term outcomes research within women’s health.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like SheMed. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.